High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients

Clinical Microbiology and Infection

Volumn 17, Issue 10, 2011, Pages 1495-1500

  van Burgel, N D ^a   Brandenburg, A ^b   Gerritsen, H J ^a   Kroes, A C M ^a   van Dam, A P ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Izore   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

C6 peptide; Lyme; Neuroborreliosis; Serology

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; C6 PEPTIDE ENZYME LINKED IMMUNOSORBENT ASSAY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 80053069625     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03459.x     Document Type: Article

References (25)

1. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992;115(Pt 2): 399-423.
2. Halperin JJ. Nervous system Lyme disease. Infect Dis Clin North Am 2008; 22: 261-274, vi.
3. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18: 484-509.
4. Tumani H, Nolker G, Reiber H. Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 1995; 45: 1663-1670.
5. Blanc F, Jaulhac B, Fleury M et al. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 2007; 69: 953-958.
6. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol 1999; 37: 3990-3996.
7. Zhang JR, Hardham JM, Barbour AG, Norris SJ. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 1997; 89: 275-285.
8. Liang FT, Alvarez AL, Gu Y, Nowling JM, Ramamoorthy R, Philipp MT. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J Immunol 1999; 163: 5566-5573.
9. Philipp MT, Bowers LC, Fawcett PT et al. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J Infect Dis 2001; 184: 870-878.
10. Wormser GP, Liveris D, Hanincova K et al. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease. Clin Infect Dis 2008; 47: 910-914.
11. Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for Lyme disease. Clin Infect Dis 2008; 47: 188-195.
12. Tjernberg I, Schon T, Ernerudh J, Wistedt AC, Forsberg P, Eliasson I. C6-peptide serology as diagnostic tool in neuroborreliosis. APMIS 2008; 116: 393-399.
13. Sillanpaa H, Lahdenne P, Sarvas H et al. Immune responses to borrelial VlsE IR6 peptide variants. Int J Med Microbiol 2007; 297: 45-52.
14. Skarpaas T, Ljostad U, Sobye M, Mygland A. Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis 2007; 26: 675-677.
15. Skogman BH, Croner S, Forsberg P et al. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid. Pediatr Infect Dis J 2008; 27: 605-612.
16. Vermeersch P, Resseler S, Nackers E, Lagrou K. The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid. Diagn Microbiol Infect Dis 2009; 64: 347-349.
17. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17: 8-e4.
18. Peltomaa M, McHugh G, Steere AC. The VlsE (IR6) peptide ELISA in the serodiagnosis of Lyme facial paralysis. Otol Neurotol 2004; 25: 838-841.
19. Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 1990; 161: 1203-1209.
20. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol 1991; 30: 197-205.
21. Roux F, Boyer E, Jaulhac B, Dernis E, Closs-Prophette F, Puechal X. Lyme meningoradiculitis: prospective evaluation of biological diagnosis methods. Eur J Clin Microbiol Infect Dis 2007; 26: 685-693.
22. Wilske B, Schierz G, Preac-Mursic V et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis 1986; 153: 304-314.
23. Qureshi MZ, New D, Zulqarni NJ, Nachman S. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J 2002; 21: 12-14.
24. Bennet R, Lindgren V, Zweygberg WB. Borrelia antibodies in children evaluated for Lyme neuroborreliosis. Infection 2008; 36: 463-466.
25. Fawcett PT, Rose CD, Gibney KM, Doughty RA. Correlation of seroreactivity with response to antibiotics in pediatric Lyme borreliosis. Clin Diagn Lab Immunol 1997; 4: 85-88.